4//SEC Filing
ImmunoCellular Therapeutics, Ltd. 4
Accession 0001181431-14-011932
$IMUCCIK 0000822411operating
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 5:50 PM ET
Size
9.4 KB
Accession
0001181431-14-011932
Insider Transaction Report
Form 4
FRACTOR DAVID
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2014-03-07+20,000→ 20,000 totalExercise: $1.34Exp: 2024-03-06→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over four years beginning April 7, 2014.
Issuer
ImmunoCellular Therapeutics, Ltd.
CIK 0000822411
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000822411
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 5:50 PM ET
- Size
- 9.4 KB